Cargando...
NYSE: CRL
Métricas de valuación y rentabilidad de la empresa frente a sus pares de industria. La empresa analizada aparece destacada en la primera fila.
| Empresa | Market Cap | P/E | EV/EBITDA | P/S | ROE | Margen Op. |
|---|---|---|---|---|---|---|
CRL Charles River Laboratories InteEsta empresa | $9,0B | N/A | 13,43x | 2,19x | -5,87% | 12,04% |
TMO Thermo Fisher Scientific Inc | $174,4B | N/A | 19,15x | 3,79x | 13,52% | 17,89% |
DHR Danaher Corporation | $127,5B | N/A | 17,43x | 4,89x | 7,08% | 22,94% |
IDXX IDEXX Laboratories, Inc. | $44,2B | N/A | 29,78x | 9,96x | 72,91% | 31,78% |
WAT Waters Corporation | $34,9B | N/A | 26,98x | 9,18x | 5,21% | 11,68% |
A Agilent Technologies, Inc. | $36,7B | N/A | 17,92x | 4,58x | 19,95% | 22,86% |